探索血小板P2Y1信号中的偏差:宿主防御与血液静止
Dingxin Pan1, Graham Ladds2, Khondaker Miraz Rahman3
1Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science, King's College London, London, UK.
British journal of pharmacology
|July 13, 2023
概括
血小板有不同的激活途径用于静血和炎症. 了解P2Y1受体信号差异可能会导致针对炎症性疾病的向治疗,同时保持正常的血液凝固.
科学领域:
- * 血小板生物学 血小板生物学
- * 免疫学 免疫学
- * 分子药理学分子药理学
背景情况:
- *血小板对于静血至关重要,并在炎症中发挥作用.
- *血小板激活可以导致病理性炎症,有时不会影响血液静止.
- *对于血小板功能在血液静止与炎症之间存在不同的激活通路.
研究的目的:
- *阐明血小板激活的差异信号通路.
- * 探索P2Y1受体在炎症和血液静止中的作用.
- * 了解在P2Y1受体上的偏向激素如何影响血小板功能.
主要方法:
- *对目前对P2Y1受体结构和信号传导的理解进行了回顾.
- *分析不同的血小板激活通路 (Rho-GTPase与PLCβ).
- * 考虑由内源核酸引起的偏向性激励作用.
主要成果:
- * P2Y1受体刺激对于血平衡中血小板血栓的发生至关重要.
- * P2Y1受体激活也驱动炎症,独立于静血变化.
- *Rho-GTPase信号传递,而不是PLCβ,是P2Y1介导炎症的关键.
结论:
- *血小板激活途径在血液静止和炎症之间有显著差异.
- * P2Y1受体信号表现出路径偏差,取决于激动剂.
- * 针对这些独特的途径提供了治疗性控制炎症的潜力,而不会影响血液静止.
相关概念视频
Formation of the Platelet Plug
6.7K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.7K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
566
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
566
Introduction to Hemostasis
8.4K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.4K
Extrinsic and Intrinsic Pathways of Hemostasis
8.4K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.4K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
763
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
763
Disorders of Hemostasis
999
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
999


